​Professor Kyung-Suk Suh is a distinguished expert in liver surgery, particularly in liver transplantation and hepatobiliary surgery. His expertise is highlighted by several key contributions:​

1. Extensive Clinical Experience

With approximately 40 years of medical practice, Professor Suh has established himself as a world-renowned authority in liver transplantation and liver resection. He has been instrumental in leading liver transplant teams with a remarkable success rate of 95%.

2. Pioneering Surgical Techniques

Professor Suh has been at the forefront of advancing surgical methods in liver transplantation. Notably, in April 2021, he successfully performed a liver transplant using only robotic and laparoscopic techniques without open surgery, attracting global attention. He standardized this complex procedure, achieving over 90% of donor surgeries at Seoul National University Hospital using laparoscopic methods. ​

3. Leadership in Academic Societies

Throughout his career, Professor Suh has held prominent positions in various medical societies, including:​

His leadership has significantly contributed to advancements in liver surgery and transplantation. ​

4. Educational Background and Career

Professor Suh graduated from Seoul National University College of Medicine, where he also obtained his master's and doctoral degrees. He has served as the director of Seoul National University Cancer Hospital, contributing to the advancement of cancer treatment and research. ​blog.naver.com

Through his extensive clinical experience, pioneering surgical techniques, leadership in academic societies, and dedication to medical education, Professor Kyung-Suk Suh has established himself as a leading authority in liver surgery.

​Professor Ki-Hun Kim of Asan Medical Center is a distinguished expert in liver cancer, recognized for his extensive clinical experience, pioneering surgical techniques, and leadership in hepatobiliary and pancreatic surgery.​

1. Extensive Clinical Experience

Professor Kim specializes in liver transplantation and resection for patients with hepatobiliary malignancies. In 2008, he achieved a significant milestone by performing the first purely laparoscopic donor hepatectomy in the Asia-Pacific region. As of late 2022, he has performed over 800 laparoscopic liver resections for hepatocellular carcinoma, setting a world record for a single center. ​

2. Leadership in Professional Societies

Professor Kim has held prominent positions in various medical societies, including:​

His leadership has significantly contributed to advancements in hepatobiliary and pancreatic surgery. ​

3. Contributions to Medical Education and Research

As the director of the Liver Center at Asan Medical Center, Professor Kim plays a pivotal role in advancing liver disease treatment and research. He also serves as the Secretary-General of the International Hepato-Pancreato-Biliary Association, contributing to global advancements in liver surgery. ​암센터

Through his clinical excellence, innovative surgical approaches, leadership in professional societies, and commitment to medical education and research, Professor Ki-Hun Kim has established himself as a leading authority in liver cancer treatment.

Professor Song Cheol Kim is a distinguished expert in pancreatic cancer, serving as a professor in the Department of Hepatobiliary and Pancreatic Surgery at Asan Medical Center.​

His expertise is highlighted by several key contributions:

1. Extensive Surgical Experience

Professor Kim specializes in surgeries for pancreatic, bile duct, and gallbladder diseases, performing a high volume of complex procedures with notable proficiency. 

2. Leadership in Minimally Invasive Surgery

He has advanced the use of robotic and laparoscopic techniques in hepatobiliary and pancreatic surgeries, enhancing patient outcomes through minimally invasive approaches. ​

3. Research and Innovation

Professor Kim has contributed to the development of biodegradable polymer patches loaded with anticancer drugs to prevent postoperative recurrence or metastasis of pancreatic cancer. 

4. Educational Contributions

As the Director of the Biomedical Engineering Research Center at the University of Ulsan, he has played a pivotal role in integrating engineering advancements with medical practices, particularly in pancreatic surgery. ​bmit.ulsan.ac.kr

Through his clinical excellence, innovative research, and dedication to education, Professor Song Cheol Kim has established himself as a leading authority in pancreatic cancer surgery.

Why is Professor Sang-Myeong Woo a Leading Expert in Pancreatic Cancer?

Professor Sang-Myeong Woo of the National Cancer Center Korea (NCCK) is a distinguished expert in pancreatic cancer, recognized for his contributions in clinical practice, research, and education. His expertise is highlighted by the following key achievements:

1. Extensive Clinical Experience and Specialized Research

✔ As a gastroenterology specialist, Professor Woo focuses on the diagnosis and treatment of pancreatic cancer, improving early detection and therapeutic strategies.

✔ He has conducted cutting-edge research on genetic factors in pancreatic cancer, particularly in BRCA mutations and other genetic alterations. His work has contributed to the development of personalized treatment approaches for pancreatic cancer patients.

2. Leadership in Immunotherapy and Targeted Cancer Treatment

✔ Professor Woo is actively involved in developing novel immunotherapy approaches for pancreatic cancer.

✔ As the Director of the NCCK Immune Cell Therapy Division, he leads research on innovative immunotherapy applications, aiming to enhance treatment effectiveness for patients with pancreatic cancer.

3. Contributions to Medical Education and Training

✔ Professor Woo is also an Associate Professor at the Graduate School of Cancer Science and Policy at NCCK, contributing to education and training for future oncologists and researchers.

✔ He plays a key role in bridging clinical practice and research, ensuring that the latest scientific discoveries are effectively translated into improved treatment options for pancreatic cancer patients.

4. Global Recognition and Impact

✔ His research has significantly influenced international pancreatic cancer treatment guidelines, particularly in the areas of genetic testing and immunotherapy applications.

✔ Professor Woo’s contributions to personalized medicine and targeted therapies have helped improve the prognosis of patients with advanced-stage pancreatic cancer.

Conclusion: A Leading Authority in Pancreatic Cancer

With his clinical expertise, groundbreaking research, leadership in immunotherapy, and commitment to education, Professor Sang-Myeong Woo has established himself as one of South Korea’s top pancreatic cancer specialists.

✔ Expert in pancreatic cancer diagnosis, treatment, and genetic research

✔  Leader in immunotherapy and targeted therapy for pancreatic cancer

✔  Key contributor to international cancer research and treatment guidelines

✔  Dedicated educator shaping the future of oncology and pancreatic cancer care

His contributions continue to advance pancreatic cancer treatment and improve patient outcomes.

​

​Professor Hee Cheol Kim is a distinguished expert in colorectal cancer, serving in the Division of Colon and Rectal Surgery at Samsung Medical Center. His expertise is highlighted by several key contributions:​

1. Specialized Clinical Focus

Professor Kim's clinical practice is centered on:​

This specialized focus has enabled him to develop extensive experience in diagnosing and surgically treating various colorectal malignancies. 

2. Leadership in Minimally Invasive Surgical Techniques

He is proficient in minimally invasive surgical techniques, such as laparoscopic and robotic surgeries, including single-port laparoscopic surgery, which offer patients benefits like reduced postoperative pain, shorter hospital stays, and faster recovery times. 

3. Research on Psychological Distress and Cancer Outcomes

Professor Kim has contributed to research exploring the impact of psychological distress on cancer outcomes. His team found that high distress levels at the time of colorectal cancer diagnosis are associated with increased risks of recurrence and mortality, highlighting the importance of comprehensive patient care. 

Through his clinical expertise, innovative surgical approaches, and dedication to advancing colorectal oncology, Professor Hee Cheol Kim has established himself as a leading authority in colorectal cancer treatment.

​Professor Hyung Ryul Kim is a distinguished thoracic surgeon at Asan Medical Center in Seoul, South Korea, specializing in lung cancer. His expertise is demonstrated through the following key aspects:​

1. Specialized Clinical Focus

Professor Kim's medical practice is centered on:​

This specialized focus has enabled him to develop extensive experience in diagnosing and surgically treating various thoracic malignancies. 

2. Advanced Surgical Techniques

He is proficient in minimally invasive surgical techniques, such as video-assisted thoracoscopic surgery (VATS) and robotic surgery, which offer patients benefits like reduced postoperative pain, shorter hospital stays, and faster recovery times. ​

3. Research and Academic Contributions

Professor Kim has contributed to thoracic oncology through research, including studies on:​

His work has been recognized by the Korean Society for Thoracic and Cardiovascular Surgery, which awarded him and his team the Excellent Overseas Paper Award for their study validating the International Association for the Study of Lung Cancer's (IASLC) proposed residual tumor classification in stage III NSCLC patients. ​medifonews.com

4. Patient Education and Public Awareness

Beyond clinical and research endeavors, Professor Kim actively engages in patient education and public awareness initiatives, emphasizing the importance of early detection and prevention strategies for lung cancer.​

Through his clinical expertise, innovative surgical approaches, and dedication to advancing thoracic oncology, Professor Hyung Ryul Kim has established himself as a leading expert in lung cancer treatment.

​Professor Byoung Chul Cho is a distinguished expert in lung cancer, serving as the Director of the Lung Cancer Center at Yonsei Cancer Hospital. His expertise is underscored by several key contributions:​

1. Leadership in Clinical Trials and Drug Development

Professor Cho has played a pivotal role in the clinical development of novel therapies for non-small cell lung cancer (NSCLC). Notably, he led the clinical trials for Lazertinib (Leclaza), a third-generation EGFR tyrosine kinase inhibitor developed by Yuhan Corporation, and Amivantamab (Rybrevant), a bispecific antibody targeting EGFR and MET developed by Janssen. His leadership in these trials has expanded treatment options for patients with EGFR-mutated NSCLC. 

2. Recognition as a Highly Cited Researcher

In 2021, Professor Cho was recognized as a Highly Cited Researcher in Clinical Medicine by Clarivate, reflecting his significant impact on lung cancer research through numerous high-quality publications. 

3. International Collaboration and Influence

His expertise has garnered international attention, leading to collaborations aimed at advancing cancer research and treatment. For instance, in November 2024, the President of Latvia visited Yonsei University to engage with Professor Cho and his team, seeking to learn from their successful translational research models in oncology. 

4. Entrepreneurial Initiatives in Oncology

Beyond his academic and clinical roles, Professor Cho co-founded DaAn Bio Therapeutics in March 2020, aiming to develop innovative cancer therapies. This venture exemplifies his commitment to translating research discoveries into clinical applications that benefit patients. ​

Through these multifaceted contributions, Professor Byoung Chul Cho has established himself as a leading authority in lung cancer research and treatment, significantly advancing the field both in South Korea and globally.

Professor Bon-Kwon Koo is a distinguished expert in cardiovascular diseases, serving as a professor at Seoul National University Hospital. His expertise is demonstrated through his extensive clinical experience, pioneering research, and leadership in the field of interventional cardiology.​

1. Extensive Clinical Experience

Professor Koo has a comprehensive background in diagnosing and treating various cardiovascular conditions, including coronary artery disease, myocardial infarction, and heart failure. His clinical acumen ensures that patients receive accurate diagnoses and effective treatments.​

2. Pioneering Research in Coronary Physiology

He has conducted groundbreaking research in coronary physiology, particularly in the development and application of physiological indices such as Fractional Flow Reserve (FFR) and Resting Full-cycle Ratio (RFR). These indices are crucial for assessing the severity of coronary artery stenosis and guiding appropriate interventional strategies.​

3. Leadership in Interventional Cardiology

As a leader in interventional cardiology, Professor Koo has been instrumental in advancing percutaneous coronary intervention (PCI) techniques. His work has contributed to optimizing PCI outcomes, enhancing patient safety, and improving long-term prognoses for individuals with complex coronary artery disease.​

4. Contributions to Medical Education and Guidelines

Beyond his clinical and research endeavors, Professor Koo is actively involved in medical education, mentoring the next generation of cardiologists. He has also contributed to the development of clinical guidelines and consensus statements, influencing best practices in cardiovascular medicine both nationally and internationally.​

Through his dedication to clinical excellence, innovative research, and educational leadership, Professor Bon-Kwon Koo has established himself as a leading authority in the field of cardiovascular diseases.

Why is Professor Seung-Jung Park a Leading Expert in Interventional Cardiology?

Professor Seung-Jung Park of Asan Medical Center is widely recognized as one of South Korea’s foremost experts in interventional cardiology. His contributions to percutaneous coronary interventions (PCI), stent implantation, and cardiovascular research have significantly shaped the field of cardiology both in Korea and internationally. Here’s why he is considered a top expert in heart procedures:

1. Pioneer of Coronary Stent Procedures in South Korea

✔ First to perform coronary stent implantation in Korea (1991) – Professor Park successfully conducted Korea’s first-ever coronary artery stent procedure, marking a new era in interventional cardiology.

✔ His expertise in stent placement for coronary artery disease (CAD) has helped thousands of patients avoid open-heart surgery.

✔ He has played a key role in developing and refining stenting techniques, making interventions safer and more effective.(news.amc.seoul.kr)

2. Leader in Complex and High-Risk PCI (CHIP) Cases

✔ Expert in treating complex coronary artery diseases – Professor Park specializes in PCI for patients with:

✔ His research has helped refine the use of drug-eluting stents (DES) and advanced stent optimization techniques to improve patient outcomes.

3. Global Influence in Cardiology Research and Guidelines

✔ Published over 1,000 peer-reviewed research papers in top medical journals, including The New England Journal of Medicine (NEJM), JACC, and Circulation.

✔ His clinical trials on stents and PCI have influenced global treatment guidelines for coronary artery disease.

✔ He has led multiple international studies on PCI vs. coronary artery bypass grafting (CABG), improving patient selection for minimally invasive treatments.

His research has directly shaped how cardiologists worldwide approach PCI and stent-based treatments.

4. Educator and Mentor for Future Cardiologists

✔ As a professor at Asan Medical Center, he has trained hundreds of interventional cardiologists, many of whom now lead cardiac centers worldwide.

✔ He frequently lectures at global cardiology conferences, sharing insights on the latest PCI advancements.

✔ His work in stent design and optimization has contributed to better patient outcomes and reduced complications.

5. Recognition and Awards in Interventional Cardiology

✔ Recipient of numerous international cardiology awards, recognizing his contributions to PCI advancements.

✔ Regularly ranked among the top interventional cardiologists worldwide for his pioneering work in complex PCI.

✔ Acknowledged by European and American cardiology societies as a leader in minimally invasive heart procedures.

Conclusion: A True Pioneer in Heart Procedures

With his groundbreaking work in coronary stents, extensive research contributions, and dedication to training future cardiologists, Professor Seung-Jung Park has solidified his reputation as one of the world's top experts in interventional cardiology.

✔ First to perform coronary stent implantation in Korea

✔ Expert in complex PCI for high-risk patients

✔ Leader in global cardiology research and stent optimization

✔ Influential educator and mentor in interventional cardiology

✔ Recognized internationally for advancing heart procedures

His work has transformed the way coronary artery disease is treated, making minimally invasive heart procedures safer, more effective, and accessible to more patients worldwide.

Professor Woo Jin Hyung is a distinguished expert in gastric cancer surgery, serving at Severance Hospital, part of Yonsei University Health System. His expertise is evidenced by his extensive academic background, pioneering surgical achievements, and leadership roles in the field.​

1. Academic and Professional Background

2. Pioneering Robotic Gastric Cancer Surgery

Professor Hyung is renowned for his pioneering work in robotic-assisted gastric cancer surgeries:​

3. Leadership in Establishing Surgical Standards

His contributions have been instrumental in setting global standards for gastric cancer surgery:​

Through his innovative surgical techniques, extensive research, and commitment to advancing gastric cancer treatment, Professor Woo Jin Hyung has established himself as a leading authority in the field, significantly improving patient outcomes and setting new benchmarks in surgical oncology.

Why is Professor Sun Young Rha a Leading Expert in Gastric Cancer?

Professor Sun Young Rha is a highly respected specialist in gastric (stomach) cancer at Yonsei Cancer Hospital. She is recognized for her contributions to clinical research, innovative treatment strategies, and global leadership in gastric cancer therapy. Her expertise is demonstrated through the following key achievements:

1. Extensive Clinical Experience and Leadership

✔ Professor Rha is a medical oncologist specializing in gastric cancer treatment at Yonsei Cancer Hospital.

✔ She has been actively involved in both clinical practice and academic research, focusing on developing more effective treatments for advanced gastric cancer.

✔ She is a leading investigator in international clinical trials, setting new standards in gastric cancer therapy.

Her vast experience allows her to provide personalized treatment plans that improve survival rates and patient quality of life.

2. Pioneer in Advanced Gastric Cancer Treatment

Professor Rha has played a crucial role in developing new global treatment standards for advanced gastric cancer.

✔ Leader of the KEYNOTE-859 Clinical Trial – A groundbreaking study that successfully led to the approval of Keytruda (Pembrolizumab) as a first-line treatment for HER2-negative gastric cancer.

✔ Expert in Immunotherapy and Targeted Therapy – She has contributed to the development of combination therapies, significantly improving treatment efficacy.

✔ Innovator in Personalized Cancer Treatment – By integrating biomarker analysis, she helps identify the most effective treatment for each patient.

Her work has directly impacted global treatment guidelines, offering new hope for patients with advanced gastric cancer.(docdocdoc.co.kr)

3. Active Role in Global Gastric Cancer Research

Professor Rha is not only a clinician but also a leading researcher shaping the future of gastric cancer treatment.

✔ She collaborates with international cancer research centers, helping to advance global treatment protocols.

✔ She publishes extensively in top medical journals, contributing to the global understanding of gastric cancer.

✔ She is frequently invited to speak at international oncology conferences, sharing her insights on the latest advancements in gastric cancer therapy.

Her research and contributions ensure that patients receive the most up-to-date, scientifically backed treatments.

4. Multidisciplinary and Patient-Centered Approach

Professor Rha emphasizes a multidisciplinary approach to gastric cancer treatment, ensuring that patients receive comprehensive, well-rounded care.

✔ Works closely with surgical oncologists, radiation oncologists, and molecular biologists to provide optimal treatment.

✔ Focuses on patient quality of life, including symptom management and long-term follow-up care.

✔ Advocates for early detection and prevention strategies, helping reduce the overall burden of gastric cancer.

Her commitment to patient-centered, holistic care sets her apart as a leader in the field.

Conclusion: A Global Authority in Gastric Cancer Treatment

With her groundbreaking research, leadership in clinical trials, and commitment to patient care, Professor Sun Young Rha has established herself as a global expert in gastric cancer treatment.

✔Pioneer in immunotherapy and targeted therapy for gastric cancer

✔Leader of major international clinical trials, shaping global treatment standards

✔ Active contributor to global gastric cancer research and patient care

✔ Advocate for personalized medicine and multidisciplinary treatment approaches

Her work continues to redefine gastric cancer treatment, providing new hope for patients worldwide.

Professor Chel Hun Choi is a distinguished expert in cervical cancer treatment at Samsung Medical Center. His expertise is demonstrated through his extensive academic background, clinical experience, and significant contributions to gynecologic oncology.

1. Academic and Professional Background

2. Clinical Expertise and Innovative Surgical Techniques

Professor Choi specializes in the treatment of gynecologic cancers, including cervical, ovarian, and endometrial cancers. He is renowned for adopting advanced surgical methods that aim to preserve fertility in young patients. For instance, he performs procedures that remove only the affected cervical tissue, preserving the upper part of the uterus, thereby maintaining the patient's ability to conceive. 

3. Research and Academic Contributions

An active researcher, Professor Choi frequently engages in laboratory work to explore the pathophysiology of cervical cancer and develop improved treatment protocols. His dedication to research enhances clinical practices and contributes to the advancement of gynecologic oncology. 

4. Recognition and Peer Recommendations

In a survey conducted by Dong-A Ilbo, Professor Choi was recognized as the top cervical cancer specialist recommended by his peers. This acknowledgment reflects his exceptional skills, dedication, and the high regard in which he is held within the medical community. 

5. Public Education and Awareness

Professor Choi actively participates in public education initiatives to dispel myths and provide accurate information about cervical cancer. He emphasizes the importance of preventive measures such as regular screenings and HPV vaccinations to reduce the incidence of cervical cancer.

Through his comprehensive clinical expertise, innovative treatment approaches, and commitment to research and public education, Professor Chel Hun Choi has established himself as a leading authority in cervical cancer treatment.

​Professor Hee-Sung Kim is a distinguished expert in cervical cancer at Seoul National University Hospital (SNUH). His expertise is demonstrated through his extensive academic background, clinical experience, and contributions to gynecologic oncology.​

1. Academic and Professional Background

2. Clinical Expertise in Gynecologic Oncology

Professor Kim specializes in the diagnosis and treatment of gynecologic cancers, including cervical cancer. His clinical focus encompasses advanced surgical techniques and comprehensive patient care strategies aimed at improving outcomes for patients with gynecologic malignancies.​

3. Advocacy for Patient Education and Fertility Preservation

He actively participates in public education initiatives to raise awareness about cervical cancer prevention, early detection, and treatment options. Notably, Professor Kim addresses concerns regarding fertility preservation in patients diagnosed with gynecologic cancers, emphasizing that advancements in medical treatments have made it possible for these patients to conceive and bear children post-treatment. 

4. Contributions to Public Awareness through Media

Professor Kim has contributed to public understanding of cervical cancer by participating in educational programs and interviews. For example, he has discussed critical symptoms, diagnostic procedures, and treatment options for uterine cancers, including cervical and endometrial cancers, to inform and educate the public.

Through his extensive academic achievements, clinical expertise, dedication to patient education, and contributions to public awareness, Professor Hee-Sung Kim has established himself as a leading authority in cervical cancer treatment.

Professor Jeong Eon Lee is a distinguished expert in breast cancer treatment at Samsung Medical Center. His extensive experience and contributions to the field are highlighted by the following:

1. Academic and Professional Background

2. Leadership in Multidisciplinary Breast Cancer Treatment

Professor Lee emphasizes a multidisciplinary approach to breast cancer treatment, collaborating closely with specialists in surgery, oncology, and radiation therapy to provide comprehensive care. 

3. Advocacy for Early Detection and Patient Education

He actively educates the public on the importance of early detection and self-examination for breast cancer, highlighting that approximately two-thirds of patients discover lumps themselves before seeking medical attention. 

4. Research on Fertility Preservation in Young Breast Cancer Patients

Professor Lee has conducted significant research on fertility preservation, demonstrating that hormonal therapies during chemotherapy can protect ovarian function, enabling many patients to conceive and deliver healthy children post-treatment. 

5. Recognition Among Peers

In a survey among medical professionals, Professor Lee was highly recommended as a top breast cancer surgeon, reflecting his peers' trust in his expertise and dedication. 

Through his comprehensive clinical practice, research, and patient-centered care, Professor Jeong Eon Lee has established himself as a leading authority in breast cancer treatment.

​

Professor Young-Hoon Kim is a distinguished expert in spinal surgery at Seoul St. Mary's Hospital, recognized for his extensive clinical experience, innovative surgical techniques, and contributions to medical education.

1. Extensive Clinical Experience

With a medical degree from Seoul National University and specialized training in orthopedic surgery, Professor Kim has dedicated his career to the treatment of spinal disorders. His vast experience encompasses a wide range of spinal surgeries, including complex procedures for degenerative diseases, deformities, and spinal tumors.

2. Innovative Surgical Techniques

Professor Kim is known for adopting and developing minimally invasive surgical techniques, which aim to reduce patient recovery time and postoperative complications. His expertise in endoscopic spine surgery and percutaneous procedures has positioned him at the forefront of spinal surgery advancements.

3. Contributions to Medical Education

As a professor at Seoul St. Mary's Hospital, Professor Kim is actively involved in educating the next generation of orthopedic surgeons. He regularly publishes research in reputable medical journals and presents at international conferences, sharing his knowledge and advancements in spinal surgery.

Through his clinical expertise, innovative approaches, and commitment to education, Professor Young-Hoon Kim has established himself as a leading authority in spinal surgery.

​Dr. Hye-Sung Kim,

 the Director of Apple Tree Dental Hospital, is a distinguished expert in implant surgery, recognized for his extensive experience and contributions to the field. Key aspects of his expertise include:

1. Extensive Clinical Experience

2. Commitment to Education and Knowledge Sharing

3. Focus on Oral Microbiome Research

Through his extensive clinical experience, dedication to education, and research into the oral microbiome, Dr. Hye-Sung Kim has established himself as a leading expert in implant surgery, continually contributing to advancements in dental medicine.